A peptide that gently prompts your pituitary gland to make its own growth hormone, keeping your body's natural rhythm intact.
Body composition, sleep, recovery, and energy through growth-hormone support.
It raises IGF-1 (a growth signal linked to cell growth), so ongoing blood monitoring is essential — and it's not for anyone with cancer risk.
What it is
Sermorelin works by gently nudging your pituitary gland to produce its own growth hormone — rather than bypassing it entirely. That distinction matters. Injecting growth hormone directly tells your pituitary to stop making its own, because the feedback system senses there's enough. Sermorelin works with that feedback system instead of around it: your pituitary releases growth hormone in the same natural pulses it always has, just more of them. It's a synthetic version of the first 29 amino acids of the signal your hypothalamus normally sends to trigger that release. It was FDA-approved for growth hormone deficiency in children under the brand name Geref, and was pulled from the market in 2008 — not because of safety concerns, but for commercial reasons. Today it's used in functional and anti-aging medicine through compounding pharmacies.
Potential benefits
GH Stimulation — Pulsatile & Physiological
Reliably stimulates pulsatile GH release. Preserves pituitary feedback — avoids IGF-1 overshoot and suppression of endogenous GH seen with direct GH injection. Lower risk profile than exogenous GH.
Body Composition
GH supports lean mass, reduces visceral fat. Clinically observed with Sermorelin — magnitude depends on baseline GH levels, age, and lifestyle.
Sleep Quality
GH is predominantly released during deep sleep. Sermorelin use frequently reported to improve sleep quality. Commonly reported clinical observation.
Recovery, Energy & Cognitive Function
GH's role in tissue repair, energy, and cognitive clarity is well-established in GH physiology. Clinical observations with Sermorelin are consistent with this. Controlled adult wellness RCTs are limited.
Risks and contraindications
Side Effects
- Injection site pain · Headache · Flushing · Dizziness · Nausea
- Water retention / mild edema
- Tingling or numbness in extremities — monitor if persistent
GH Axis Risks
- IGF-1 elevation — most important long-term consideration
- Cancer risk: elevated IGF-1 is associated with increased cell proliferation
- Insulin resistance — GH reduces insulin sensitivity over time; monitor glucose
- Carpal tunnel syndrome — GH fluid retention effect
- Sleep apnea worsening in susceptible individuals
- Thyroid interaction — GH affects T4→T3 conversion
Contraindications / cautions
- Active malignancy — IGF-1 elevation is serious concern
- Proliferative diabetic retinopathy · Pregnancy · Under 18
- Intracranial tumor history · Sleep apnea (caution)
- Stacking with other GH secretagogues — requires IGF-1 monitoring
Research reality
The biology behind how growth hormone releasing hormones work is one of the most thoroughly studied areas in endocrinology. The mechanism Sermorelin operates through is well understood and well-documented in both animal research and decades of physiological study.
Meaningful human data exists from the studies that supported its original FDA approval for children with growth hormone deficiency. Adult studies draw on the broader body of growth hormone physiology research and clinical observation rather than large Sermorelin-specific adult trials.
More developed than most compounds here because of that prior FDA approval. The caveat is that the approval data came from pediatric use, which doesn't translate perfectly to adult anti-aging applications. IGF-1 monitoring isn't optional — it's the ongoing safety checkpoint that makes continued use responsible.
One of the more evidence-grounded GH-axis options. Prior FDA approval, a physiological mechanism, and long clinical experience give it a stronger foundation than most research peptides. The IGF-1 elevation risk is real — ongoing monitoring is non-negotiable. Not appropriate for anyone with active cancer or significant cancer risk.